A Phase II Trial of Azacitidine With Ipilimumab, Nivolumab, or Ipilimumab and Nivolumab in Previously Untreated Myelodysplastic Syndrome

Authors

Ian M Bouligny
Guillermo Montalban-Bravo
Koji Sasaki
Naval Daver
Elias Jabbour
Yesid Alvarado
Courtney D DiNardo
Farhad Ravandi
Gautam Borthakur
Prithviraj Bose
Naveen Pemmaraju
Steven Kornblau
Tapan Kadia
Lucia Masarova
Koichi Takahashi
Michael Andreeff
Alexandre Bazinet
Hui Yang
Rashmi Kanagal-Shamanna
Chitra Hosing
Sherry Pierce
Meghan Meyer
Xuelin Huang
Guillermo Garcia-Manero

Publication Date

7-1-2025

Journal

Haematologica

DOI

10.3324/haematol.2024.286559

PMID

39973365

PMCID

PMC12208154

PubMedCentral® Posted Date

2-20-2025

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Bouligny, Ian M; Montalban-Bravo, Guillermo; Sasaki, Koji; et al., "A Phase II Trial of Azacitidine With Ipilimumab, Nivolumab, or Ipilimumab and Nivolumab in Previously Untreated Myelodysplastic Syndrome" (2025). Faculty, Staff and Student Publications. 4359.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4359